Ashley Chan

For patients with lymphoma or multiple myeloma, speaking up about symptoms of cytokine release syndrome can be lifesaving.

From “The Young and the Restless” actress dying of cancer to “Star Trek” actress 20 years pancreatic cancer-free, here’s what’s happening in the cancer space this week.

Patients with laryngeal cancer who stopped smoking before receiving treatment had better survival outcomes, compared with patients who actively smoke.

During chemo shortages, nurses have helped many patients receive enough treatment, measuring them down to the “minutiae of the milligrams.”

Receiving early transfusions and treatment to reduce transfusion dependency significantly improves survival and quality of life in low-risk MDS.

Treatment with Enhertu “is an unprecedented approval” for patients with HER2-positive solid tumors who did not have many options, an expert told CURE®.

A cognitive behavioral therapy for insomnia may help cancer survivors, along with ways to manage insomnia via sleep pressure, an expert told CURE®.

The survival benefit observed with Padcev plus Keytruda was “unlike anything we’d seen before” for advanced bladder cancer, according to an expert.

From the Allman Brothers Band’s singer Dickey Betts dying after a cancer diagnosis to the “Shopaholic” author announcing her glioblastoma diagnosis, here’s what is happening in the cancer space this week.

Two immune checkpoint inhibitors are being evaluated together in a phase 1 trial for certain patients with advanced solid tumors.

There was not a significant difference between presurgical and postsurgical chemotherapy in patients with locally advanced colon cancer, researchers found.

From Patrick Swayze’s widow recalling his pancreatic cancer diagnosis to Demi Moore speaking about her aunt’s courage during cancer, here’s what’s going on in the oncology space this week.

Treatment of Adriamycin, a type of chemotherapy, may be linked with breast cancer in Hodgkin lymphoma survivors, a study showed.

Exercise and physical activity can help patients with advanced breast cancer, especially with quality of life, two experts told CURE®.

Patients with prostate cancer receiving ADT who are vitamin D deficient may receive the most bone density benefits from high-dose vitamin D.

The novel treatment, zanidatamab, has been submitted to the FDA via a Biologics License Application for patients with HER2-positive biliary tract cancer.

Certain levels of immune cells in the breast tissue were associated with better survival in triple-negative breast cancer, according to recent research.

Enhertu has been approved by the FDA for certain patients with unresectable or metastatic HER2-positive solid tumors.

Since January 2024, the Food and Drug Administration has approved several treatments and combinations for solid tumors.

From WWE champion Roman Reigns sharing about his leukemia status to Arizona rep. Raúl Grijalva announcing diagnosis, here’s what’s going on in the oncology space this week.

Treatment with immune checkpoint inhibitors has improved survival outcomes for patients with metastatic bladder cancer, compared with chemotherapy.

Childbirth rates have been reduced by 22% in women with MPNs, compared with women without MPNs, researchers found.

Melanoma survivors may have an increased risk of recurrence, which may heighten fear and worry, but “it’s OK and normal to be worried,” a doctor said.

Men with breast cancer tend to have two peaks of time when the risk for breast cancer-specific mortality is increased, compared with women, a study showed.

From Fortnight player, “Ninja” announcing his melanoma diagnosis to an LSU quarterback sporting the name of his teammate with brain cancer, here’s what’s going on in the oncology space this week.

Comprehensive biomarker testing and “timely” testing is “important” for patients with a specific lung cancer subset, an expert said.

The GI cancer space has “made huge strides” in recent years, which opened more options for patients with a type of esophageal cancer, an expert said.

Musical play engages children with cancer, which relieves stress for them and their parents/caregivers, an expert said.

Certain oral chemotherapies may cause hand-foot syndrome, but reducing the dose of the drug allows it to heal, an expert told CURE®.

A phase 3 trial determined that Tivdak showed “game-changing results” for certain patients with cervical cancer, an expert told CURE®.